Olsalazine in the Treatment of Ulcerative Colitis among Patients Intolerant of Sulphasalazine: A Prospective, Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging Clinical Trial

S. Meyers; D. B. Sachar; D. H. Present; H. D. Janowitz

doi:10.3109/00365528809101544

Olsalazine in the Treatment of Ulcerative Colitis among Patients Intolerant of Sulphasalazine: A Prospective, Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging Clinical Trial

Scandinavian Journal of Gastroenterology ◽

10.3109/00365528809101544 ◽

1988 ◽

Vol 23 (sup148) ◽

pp. 29-37 ◽

Cited By ~ 17

Author(s):

S. Meyers ◽

D. B. Sachar ◽

D. H. Present ◽

H. D. Janowitz

Keyword(s):

Ulcerative Colitis ◽

Clinical Trial ◽

Double Blind ◽

Dose Ranging

Download Full-text

Randomised clinical trial: a phase 1, dose-ranging study of the anti-matrix metalloproteinase-9 monoclonal antibody GS-5745 versus placebo for ulcerative colitis

Alimentary Pharmacology & Therapeutics ◽

10.1111/apt.13653 ◽

2016 ◽

Vol 44 (2) ◽

pp. 157-169 ◽

Cited By ~ 34

Author(s):

W. J. Sandborn ◽

B. R. Bhandari ◽

R. Fogel ◽

J. Onken ◽

E. Yen ◽

...

Keyword(s):

Ulcerative Colitis ◽

Clinical Trial ◽

Monoclonal Antibody ◽

Matrix Metalloproteinase ◽

Phase 1 ◽

Randomised Clinical Trial ◽

Matrix Metalloproteinase 9 ◽

Dose Ranging ◽

Metalloproteinase 9

Download Full-text

A Randomized, double-blind, dose ranging clinical trial of intravenous FDY-5301 in acute stemi patients undergoing primary PCI

International Journal of Cardiology ◽

10.1016/j.ijcard.2021.11.016 ◽

2021 ◽

Author(s):

David Adlam Dhil ◽

Maciej Zarebinski ◽

Neal G. Uren ◽

Pawel Ptaszynski ◽

Keith G. Oldroyd ◽

...

Keyword(s):

Clinical Trial ◽

Primary Pci ◽

Double Blind ◽

Acute Stemi ◽

Dose Ranging

Download Full-text

Efficacy and safety of a standardized extract from Achillea wilhelmsii C. Koch in patients with ulcerative colitis: A randomized double blind placebo-controlled clinical trial

Complementary Therapies in Medicine ◽

10.1016/j.ctim.2019.05.001 ◽

2019 ◽

Vol 45 ◽

pp. 262-268 ◽

Cited By ~ 2

Author(s):

Mahtab Amiri ◽

Jafar Navabi ◽

Yalda Shokoohinia ◽

Fatemeh Heydarpour ◽

Gholamreza Bahrami ◽

...

Keyword(s):

Ulcerative Colitis ◽

Clinical Trial ◽

Controlled Clinical Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Achillea Wilhelmsii

Download Full-text

Cobitolimod for moderate-to-severe, left-sided ulcerative colitis (CONDUCT): a phase 2b randomised, double-blind, placebo-controlled, dose-ranging induction trial

The Lancet Gastroenterology & Hepatology ◽

10.1016/s2468-1253(20)30301-0 ◽

2020 ◽

Vol 5 (12) ◽

pp. 1063-1075 ◽

Cited By ~ 1

Author(s):

Raja Atreya ◽

Laurent Peyrin-Biroulet ◽

Andrii Klymenko ◽

Monica Augustyn ◽

Igor Bakulin ◽

...

Keyword(s):

Ulcerative Colitis ◽

Double Blind ◽

Double Blind Placebo ◽

Dose Ranging

Download Full-text

Novel STAT3 Selective Inhibitor Natura-α Shows Great Promises in Treating Moderate-to-severe Ulcerative Colitis in a Randomized, Double-blind, Placebo-controlled Phase II Clinical Trial

The American Journal of Gastroenterology ◽

10.14309/00000434-201210001-01582 ◽

2012 ◽

Vol 107 ◽

pp. S638

Author(s):

Longgui Wang ◽

Simon Mencher ◽

Sunil Khurana ◽

Barry Kaufman ◽

Robert Hardi ◽

...

Keyword(s):

Ulcerative Colitis ◽

Clinical Trial ◽

Phase Ii ◽

Selective Inhibitor ◽

Phase Ii Clinical Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Severe Ulcerative Colitis

Download Full-text

Adsorptive Granulocyte/Monocyte Apheresis for the Maintenance of Remission in Patients with Ulcerative Colitis: A Prospective Randomized, Double Blind, Sham-Controlled Clinical Trial

Gut and Liver ◽

10.5009/gnl.2012.6.4.427 ◽

2012 ◽

Vol 6 (4) ◽

pp. 427-433 ◽

Cited By ~ 12

Author(s):

Ken Fukunaga ◽

Yoko Yokoyama ◽

Koji Kamokozuru ◽

Kazuko Nagase ◽

Shiro Nakamura ◽

...

Keyword(s):

Ulcerative Colitis ◽

Clinical Trial ◽

Controlled Clinical Trial ◽

Double Blind ◽

Maintenance Of Remission

Download Full-text

The effect of cannabidiol on simulated car driving performance: A randomised, double‐blind, placebo‐controlled, crossover, dose‐ranging clinical trial protocol

Human Psychopharmacology Clinical and Experimental ◽

10.1002/hup.2749 ◽

2020 ◽

Vol 35 (5) ◽

Author(s):

Danielle McCartney ◽

Melissa J. Benson ◽

Anastasia S. Suraev ◽

Christopher Irwin ◽

Thomas R. Arkell ◽

...

Keyword(s):

Clinical Trial ◽

Driving Performance ◽

Trial Protocol ◽

Double Blind ◽

Double Blind Placebo ◽

Clinical Trial Protocol ◽

Dose Ranging ◽

Car Driving

Download Full-text

Vitamin D suppresses proangiogenic factors in patients with ulcerative colitis: A randomized double blind placebo controlled clinical trial

Complementary Therapies in Clinical Practice ◽

10.1016/j.ctcp.2020.101086 ◽

2020 ◽

Vol 39 ◽

pp. 101086

Author(s):

Mohammad Reza Emami ◽

Amrollah Sharifi ◽

Mehdi yaseri ◽

Hoda Derakhshanian ◽

Mohammad Javad Hosseinzadeh-Attar

Keyword(s):

Ulcerative Colitis ◽

Clinical Trial ◽

Vitamin D ◽

Controlled Clinical Trial ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Tazofelone: A double-blind dose-ranging multicenter trial in distal ulcerative colitis

Gastroenterology ◽

10.1016/0016-5085(95)27429-4 ◽

1995 ◽

Vol 108 (4) ◽

pp. A780

Keyword(s):

Ulcerative Colitis ◽

Multicenter Trial ◽

Double Blind ◽

Distal Ulcerative Colitis ◽

Dose Ranging

Download Full-text

P206 - Which patient population profits best from a high dose, once daily treatment with 3.0g mesalazine for maintaining clinical remission in ulcerative colitis? A subgroup analysis of a double-blind, double-dummy, randomised, controlled, dose-ranging study

Journal of Crohn s and Colitis ◽

10.1016/s1873-9946(09)60233-6 ◽

2009 ◽

Vol 3 (1) ◽

pp. S92

Author(s):

W. Kruis ◽

L. Jonaitis ◽

L. Kupcinskas ◽

J. Pokrotnieks ◽

G. Acute ◽

...

Keyword(s):

Ulcerative Colitis ◽

Subgroup Analysis ◽

Clinical Remission ◽

Patient Population ◽

Daily Treatment ◽

High Dose ◽

Double Blind ◽

Once Daily ◽

Dose Ranging ◽

Randomised Controlled

Download Full-text